Overview

Safety and Efficacy Predimenol for Headache

Status:
COMPLETED

Trial end date:
2024-10-15

Target enrollment:

Participant gender:

Summary

This is a prospective, double-blind, placebo-controlled and randomized study aimed to obtain a description of the efficacy and safety of Predimenol in alleviating headache.

Phase:

PHASE2

Details

Lead Sponsor:

Dexa Medica Group

Collaborator:

Fakultas Kedokteran Universitas Indonesia